Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers

NCT02183428 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1356
DRUG: Glyburide
DRUG: BI 1356 + Glyburide

Sponsor

Boehringer Ingelheim